Literature DB >> 29728838

Interaction between nonsynonymous polymorphisms in PLA2G7 gene and smoking on the risk of coronary heart disease in a Chinese population.

Yunpeng Chi1, Conghong Shi2, Xiaojiang Zhang3, Yang Xi4.   

Abstract

To investigate the impact of PLA2G7 polymorphism, and additional their interactions with smoking and drinking on coronary heart disease (CHD) risk based on Chinese population. GMDR model was used to screen the best gene-smoking and gene-drinking interaction combinations. Logistic regression was performed to investigate association between 4 SNPs and CHD, and the interaction effect between rs1805017 and smoking. For CHD patient-control haplotype analyses, the SHEsis online haplotype analysis software ( http://analysis.bio-x.cn/myAnalysis.php ) was employed. CHD risks were higher in carriers of homozygous mutant of rs1805017 and rs1805018 than those with wild-type homozygotes, OR (95% CI) were 1.45 (1.16-1.92) and 1.51 (1.23-1.97), respectively, but the other two SNPs, rs16874954 and rs1051931 were not significant associated with CHD risks. GMDR analysis indicated that there was a significant two-locus model (p = 0.0107) involving rs1805017 and smoking, indicating a potential gene-environment interaction between rs1805017 and smoking. But we did not found any gene-drinking and gene-gene interaction combinations in GMDR models. The haplotype R-I was observed most frequently in two groups, with 47.43 and 54.38% in the case and control group of the population, respectively. The results also indicated that the haplotype containing the rs1805017-H and rs1805018-T alleles were associated with a statistically increased CHD risk, OR (95% CI) 1.43 (1.10-1.86), p = 0.0021. Polymorphisms in rs1805017 and rs1805018, additional interaction between rs1805017 and smoking, and haplotype containing the rs1805017-H and rs1805018-T alleles were associated with increased CHD risk.

Entities:  

Keywords:  Coronary heart disease; Drinking; Haplotype; Interaction; PLA2G7; SNP; Smoking

Mesh:

Substances:

Year:  2018        PMID: 29728838     DOI: 10.1007/s11239-018-1671-9

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  23 in total

1.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

2.  Platelet-activating factor-acetylhydrolase A379V (exon 11) gene polymorphism is an independent and functional risk factor for premature myocardial infarction.

Authors:  P-Y Liu; Y-H Li; H-L Wu; T-H Chao; L-M Tsai; L-J Lin; G-Y Shi; J-H Chen
Journal:  J Thromb Haemost       Date:  2006-05       Impact factor: 5.824

3.  Nonsynonymous polymorphisms in PLA2G7 gene are associated with the risk of coronary heart disease in a southern Chinese population.

Authors:  Mei Hong; Mengyao Zhang; Xiang Lu
Journal:  Mamm Genome       Date:  2015-02-18       Impact factor: 2.957

4.  Comprehensive genetic analysis of the platelet activating factor acetylhydrolase (PLA2G7) gene and cardiovascular disease in case-control and family datasets.

Authors:  Beth S Sutton; David R Crosslin; Svati H Shah; Sarah C Nelson; Anthony Bassil; A Brent Hale; Carol Haynes; Pascal J Goldschmidt-Clermont; Jeffery M Vance; David Seo; William E Kraus; Simon G Gregory; Elizabeth R Hauser
Journal:  Hum Mol Genet       Date:  2008-01-18       Impact factor: 6.150

5.  Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease.

Authors:  Ewa Ninio; David Tregouet; Jean-Luc Carrier; Dominique Stengel; Christoph Bickel; Claire Perret; Hans J Rupprecht; François Cambien; Stefan Blankenberg; Laurence Tiret
Journal:  Hum Mol Genet       Date:  2004-04-28       Impact factor: 6.150

6.  Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments.

Authors:  J C Charniot; R Khani-Bittar; J P Albertini; P Giral; C Cherfils; C Cosson; E Guillerm; P Leprince; I Gandjbakhch; D Bonnefont-Rousselot
Journal:  Int J Cardiol       Date:  2012-10-24       Impact factor: 4.164

7.  Associations of PLA2G7 gene polymorphisms with plasma lipoprotein-associated phospholipase A2 activity and coronary heart disease in a Chinese Han population: the Beijing atherosclerosis study.

Authors:  Liping Hou; Shufeng Chen; Hongjiang Yu; Xiangfeng Lu; Jianhong Chen; Laiyuan Wang; Jianfeng Huang; Zhongjie Fan; Dongfeng Gu
Journal:  Hum Genet       Date:  2008-11-26       Impact factor: 4.132

8.  Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials.

Authors:  J L Mega; N O Stitziel; S Kathiresan; M S Sabatine; J G Smith; D I Chasman; M Caulfield; J J Devlin; F Nordio; C Hyde; C P Cannon; F Sacks; N Poulter; P Sever; P M Ridker; E Braunwald; O Melander
Journal:  Lancet       Date:  2015-03-04       Impact factor: 79.321

9.  Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease.

Authors:  Wei Gao; Hui-Wei He; Ze-Mu Wang; Huan Zhao; Xiao-Qing Lian; Yong-Sheng Wang; Jun Zhu; Jian-Jun Yan; Ding-Guo Zhang; Zhi-Jian Yang; Lian-Sheng Wang
Journal:  Lipids Health Dis       Date:  2012-05-15       Impact factor: 3.876

10.  Circulating concentrations of endothelin-1 predict coronary heart disease in women but not in men: a longitudinal observational study in the Vara-Skövde Cohort.

Authors:  Bledar Daka; Josefin Olausson; Charlotte A Larsson; Margareta I Hellgren; Lennart Råstam; Per-Anders Jansson; Ulf Lindblad
Journal:  BMC Cardiovasc Disord       Date:  2015-11-14       Impact factor: 2.298

View more
  3 in total

Review 1.  Lipoprotein-associated phospholipase A2: The story continues.

Authors:  Fubao Huang; Kai Wang; Jianhua Shen
Journal:  Med Res Rev       Date:  2019-05-29       Impact factor: 12.944

2.  Gene-diet interactions and cardiovascular diseases: a systematic review of observational and clinical trials.

Authors:  Zayne M Roa-Díaz; Julian Teuscher; Magda Gamba; Marvin Bundo; Giorgia Grisotto; Faina Wehrli; Edna Gamboa; Lyda Z Rojas; Sergio A Gómez-Ochoa; Sanne Verhoog; Manuel Frias Vargas; Beatrice Minder; Oscar H Franco; Abbas Dehghan; Raha Pazoki; Pedro Marques-Vidal; Taulant Muka
Journal:  BMC Cardiovasc Disord       Date:  2022-08-20       Impact factor: 2.174

3.  Differentially-expressed mRNAs, microRNAs and long noncoding RNAs in intervertebral disc degeneration identified by RNA-sequencing.

Authors:  Zhimin Li; Yu Sun; Maolin He; Jianwei Liu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.